Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT02450201
What this trial is testing

MRI With C13 Pilot Study Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 5
Not applicableStudy completedNCT02816983
What this trial is testing

SBRT for Oligometastatic Castration-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 89
Testing effectiveness (Phase 2)Looking for participantsNCT04249154
What this trial is testing

Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre 77
Testing effectiveness (Phase 2)Study completedNCT06472531
What this trial is testing

PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer

Who this might be right for
Healthy Male SubjectsSuspected Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 32
Not applicableStudy completedNCT01682941
What this trial is testing

Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen

Who this might be right for
Recurrent Prostate CancerStage IV Prostate Cancer
Ohio State University Comprehensive Cancer Center 32
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Testing effectiveness (Phase 2)Looking for participantsNCT06262139
What this trial is testing

Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

Who this might be right for
MRI Scan
Songqi Gao 12
Testing effectiveness (Phase 2)UnknownNCT01682772
What this trial is testing

TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 148
Very early researchStudy completedNCT02420977
What this trial is testing

Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Not applicableEnded earlyNCT01076751
What this trial is testing

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Prostatic Neoplasms
Sanofi 82
Not applicableUnknownNCT04034953
What this trial is testing

Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong

Who this might be right for
ObesityColorectal CancerProstate Cancer+1 more
Chinese University of Hong Kong 10,000
Not applicableLooking for participantsNCT03650595
What this trial is testing

MRI Guided Focal Laser Ablation of Prostate Cancer

Who this might be right for
Prostate CancerLow and Intermediate Risk Prostate Cancer
University Health Network, Toronto 102
Large-scale testing (Phase 3)Study completedNCT05197257
What this trial is testing

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Colorado, Denver 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848337
What this trial is testing

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticNeuroendocrine Tumors
University of Michigan Rogel Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT05516329
What this trial is testing

Study of 18F-Thretide PET/CT in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Fujian Medical University 49
Testing effectiveness (Phase 2)UnknownNCT02282137
What this trial is testing

68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer

Who this might be right for
Prostate Cancer
Ebrahim Delpassand 208
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableWithdrawnNCT04486846
What this trial is testing

Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)

Who this might be right for
Prostate Cancer
Duke University
Large-scale testing (Phase 3)Study completedNCT03404648
What this trial is testing

Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI

Who this might be right for
Prostate Adenocarcinoma
Mayo Clinic 19
Not applicableUnknownNCT02739048
What this trial is testing

Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.

Who this might be right for
Prostate Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 80
Next Page